203924-60-1

Basic information

• Product Name: 4-MESITYL-5-METHYL-1H-PYRAZOL-3-AMINE
• Synonyms: 4-MESITYL-5-METHYL-1H-PYRAZOL-3-AMINE;5-Methyl-4-(2,4,6-trimethyl-phenyl)-2H-pyrazol-3-ylamine
• CAS NO: 203924-60-1
• Molecular Formula: C₁₃H₁₇N₃
• Molecular Weight: 215.29
• Mol File: 203924-60-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 359.5±30.0 °C(Predicted)
• Appearance: /
• Density: 1.111±0.06 g/cm3(Predicted)
• PKA: 16.04±0.50(Predicted)
• CAS DataBase Reference: 4-MESITYL-5-METHYL-1H-PYRAZOL-3-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-MESITYL-5-METHYL-1H-PYRAZOL-3-AMINE(203924-60-1)
• EPA Substance Registry System: 4-MESITYL-5-METHYL-1H-PYRAZOL-3-AMINE(203924-60-1)

Safety Data

• Hazardous Substances Data: 203924-60-1(Hazardous Substances Data)

Upstream product

• 59146-33-7 2-mesityl-acetoacetonitrile 

Downstream Products

• 203924-61-2 2,5-Dimethyl-3(2,4,6-trimethyl-phenyl)-4H-pyrazolo[1,5-a]pyrimidin-7-one 
• 344293-45-4 ethyl 2-(3-mesityl-2,5-dimethyl-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)acetate 
• 344293-20-5 6-(2-hydroxyethyl)-3-mesityl-2,5-dimethyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-7-one 
• 344291-97-0 3-Mesityl-2,5-dimethyl-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyrimidine 
• 344293-61-4 ethyl 3-mesityl-2,5-dimethyl-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-carboxylate 
• 332179-70-1 N-(2-aminoethyl)-3-mesityl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amine 
• 203924-64-5 7-chloro-2,5-dimethyl-3-(2,4,6-trimethylphenyl)-pyrazolo[1,5-a]pyrimidine 
• 332225-51-1 C₂₄H₃₃N₅ 
• 344293-66-9 6-(3-Hydroxyhexyl)-3-mesityl-2,5-dimethyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-7-one 

Relevant articles and documents

Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists

A novel series of pyrazolo[1,5-a]pyrimidine derivatives was synthesized and evaluated as NPY Y1R antagonists. High binding affinity and selectivity were achieved with C3 trisubstituted aryl groups and C7 substituted 2-(tetrahydro-2H-pyran-4-ylamino)ethyla

SUBSTITUTED 6,5-HETERO-BICYCLIC DERIVATIVES

This invention relates to compounds of the formula wherein A, B, D, E K, I, G, R3 and R5 are defined as in the specification, and to the pharmaceutically acceptable salts of such compounds.